Understanding Adjuvant Therapy for Upper Tract Urothelial Carcinoma

J Clin Oncol. 2024 May 1;42(13):1459-1461. doi: 10.1200/JCO.23.02679. Epub 2024 Feb 15.

Authors

Stephanie A Berg¹, Matthew D Galsky²

Affiliations

¹ Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
² Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY.

PMID: 38359384
DOI: 10.1200/JCO.23.02679

No abstract available

Publication types

Editorial

MeSH terms

Carcinoma, Transitional Cell / drug therapy
Carcinoma, Transitional Cell / pathology
Carcinoma, Transitional Cell / therapy
Chemotherapy, Adjuvant
Humans
Urologic Neoplasms* / drug therapy
Urologic Neoplasms* / pathology